Sabina A Murphy

17PUBLICATIONS
88CO-AUTHORS
Stochastic analysis and modellingCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 08, 2026
Total Event Analysis in Cardiovascular Outcome Trials: Approaches and Interpretation.

|May 25, 2026
Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

|May 19, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

|May 11, 2026
Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE.

|Mar 30, 2026
Competing Risks in Cardiovascular Research: A Practical Perspective.

Andrea Bellavia, Sabina A Murphy

|Mar 30, 2026
Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

Pageof 3

Frequent Collaborators

10 joint publications

Andrea Bellavia

8 joint publications

Marc S Sabatine

7 joint publications

Robert P Giugliano

5 joint publications

Brian A Bergmark